Recent progress in the use of periplocin, periplocymarin and periplogenin in cancer treatment

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Sum=22

Aug 24, 2025 (publication date) through Aug 20, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Aug 24, 2025; 16(8): 107490
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107490

Full Size Figure Download Figure

Figure 1 Compound structure. A: Structural formula of periplocin; B: Structural formula of periplocymarin; C: Structural formula of periplogenin.

Citation: Sun X, Shi XW, Han L, Zhang YF, Xu Y, Lu YC. Recent progress in the use of periplocin, periplocymarin and periplogenin in cancer treatment. World J Clin Oncol 2025; 16(8): 107490
URL: https://www.wjgnet.com/2218-4333/full/v16/i8/107490.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i8.107490